肺炎球菌脑膜炎中的癫痫预防,队列研究。

IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Epilepsia Open Pub Date : 2024-09-30 DOI:10.1002/epi4.13054
Lluïsa Guillem, Guillermo Hernández-Pérez, Damaris Berbel, Ivan Pelegrín, Mercè Falip, Carmen Cabellos
{"title":"肺炎球菌脑膜炎中的癫痫预防,队列研究。","authors":"Lluïsa Guillem,&nbsp;Guillermo Hernández-Pérez,&nbsp;Damaris Berbel,&nbsp;Ivan Pelegrín,&nbsp;Mercè Falip,&nbsp;Carmen Cabellos","doi":"10.1002/epi4.13054","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>Our aim was to assess seizure development as a complication of pneumococcal meningitis and its possible prevention with antiseizure medication prophylaxis.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Antiseizure medication (ASM) prophylaxis has been practiced for a long time at our center. We assessed all cases of community-acquired pneumococcal meningitis admitted from January 2010 to April 2021 recorded in our prospective database and conducted further retrospective studies.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of the 86 cases recorded, 21 (24.4%) developed acute symptomatic seizures, more than half of which (11/21; 52.4%) before admission. Seizure development increased the need for orotracheal intubation and intensive care unit admission, while also lengthening hospital stays and suggesting more risk of death and disability at discharge [adjusted odds ratio (aOR), 3.13; 95% confidence interval (CI): 1–9.8]. Of the 74 patients eligible for ASM prophylaxis, 64 received it and 10 did not. ASM prophylaxis seemed effective in preventing seizure development, as only six seizure events were recorded in 64 patients with ASM prophylaxis (9.4%) compared with four in the 10 patients without prophylaxis (40%). Its preventive capacity was especially notable when administered within 4 h of admission. Differences in mortality did not reach statistical significance. Adverse effects were rare.</p>\n </section>\n \n <section>\n \n <h3> Significance</h3>\n \n <p>Seizure development is a common complication in pneumococcal meningitis and is associated with increased risks of Intensive Care Unit admission, orotracheal intubation, and longer hospital stays. ASM prophylaxis may be effective in blocking seizure development in patients with preventable seizures and may be associated with better prognosis. Further studies are now warranted.</p>\n </section>\n \n <section>\n \n <h3> Plain Language Summary</h3>\n \n <p>Infection of the meninges (the covering of the brain) due to the common bacteria <i>S pneumoniae</i>, used to be a fatal disease before the introduction of antibiotics and corticoids. Thanks to these drugs, more people survive this disease but, due to the frequent complications, they may have several sequelae. Seizures are a common complication. Our study suggests that they might be prevented by using antiseizure drugs which may reduce both severity and hospital stay.</p>\n </section>\n </div>","PeriodicalId":12038,"journal":{"name":"Epilepsia Open","volume":"9 6","pages":"2319-2330"},"PeriodicalIF":2.8000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633693/pdf/","citationCount":"0","resultStr":"{\"title\":\"Seizure prophylaxis in pneumococcal meningitis, cohort study\",\"authors\":\"Lluïsa Guillem,&nbsp;Guillermo Hernández-Pérez,&nbsp;Damaris Berbel,&nbsp;Ivan Pelegrín,&nbsp;Mercè Falip,&nbsp;Carmen Cabellos\",\"doi\":\"10.1002/epi4.13054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>Our aim was to assess seizure development as a complication of pneumococcal meningitis and its possible prevention with antiseizure medication prophylaxis.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Antiseizure medication (ASM) prophylaxis has been practiced for a long time at our center. We assessed all cases of community-acquired pneumococcal meningitis admitted from January 2010 to April 2021 recorded in our prospective database and conducted further retrospective studies.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Of the 86 cases recorded, 21 (24.4%) developed acute symptomatic seizures, more than half of which (11/21; 52.4%) before admission. Seizure development increased the need for orotracheal intubation and intensive care unit admission, while also lengthening hospital stays and suggesting more risk of death and disability at discharge [adjusted odds ratio (aOR), 3.13; 95% confidence interval (CI): 1–9.8]. Of the 74 patients eligible for ASM prophylaxis, 64 received it and 10 did not. ASM prophylaxis seemed effective in preventing seizure development, as only six seizure events were recorded in 64 patients with ASM prophylaxis (9.4%) compared with four in the 10 patients without prophylaxis (40%). Its preventive capacity was especially notable when administered within 4 h of admission. Differences in mortality did not reach statistical significance. Adverse effects were rare.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Significance</h3>\\n \\n <p>Seizure development is a common complication in pneumococcal meningitis and is associated with increased risks of Intensive Care Unit admission, orotracheal intubation, and longer hospital stays. ASM prophylaxis may be effective in blocking seizure development in patients with preventable seizures and may be associated with better prognosis. Further studies are now warranted.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Plain Language Summary</h3>\\n \\n <p>Infection of the meninges (the covering of the brain) due to the common bacteria <i>S pneumoniae</i>, used to be a fatal disease before the introduction of antibiotics and corticoids. Thanks to these drugs, more people survive this disease but, due to the frequent complications, they may have several sequelae. Seizures are a common complication. Our study suggests that they might be prevented by using antiseizure drugs which may reduce both severity and hospital stay.</p>\\n </section>\\n </div>\",\"PeriodicalId\":12038,\"journal\":{\"name\":\"Epilepsia Open\",\"volume\":\"9 6\",\"pages\":\"2319-2330\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633693/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Epilepsia Open\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/epi4.13054\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epilepsia Open","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/epi4.13054","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的我们的目的是评估作为肺炎球菌脑膜炎并发症的癫痫发作及其通过抗癫痫药物预防的可能性:本中心长期采用抗癫痫药物(ASM)预防。我们评估了前瞻性数据库中记录的 2010 年 1 月至 2021 年 4 月期间收治的所有社区获得性肺炎球菌脑膜炎病例,并进行了进一步的回顾性研究:在记录的86例病例中,21例(24.4%)出现急性症状发作,其中一半以上(11/21;52.4%)在入院前发作。癫痫发作增加了气管插管和入住重症监护室的需要,同时也延长了住院时间,并提示出院时死亡和残疾的风险增加[调整赔率比(aOR),3.13;95% 置信区间(CI):1-9.8]。在符合 ASM 预防条件的 74 名患者中,64 人接受了 ASM 预防,10 人未接受。ASM预防似乎能有效预防癫痫发作,因为在64名接受ASM预防的患者中仅记录到6起癫痫发作事件(9.4%),而在10名未接受预防的患者中则记录到4起(40%)。在入院 4 小时内进行预防性治疗的效果尤为显著。死亡率方面的差异没有统计学意义。不良反应很少:意义:癫痫发作是肺炎球菌脑膜炎的常见并发症,与重症监护室入院、气管插管和住院时间延长的风险增加有关。预防性 ASM 可有效阻止可预防性癫痫发作患者的癫痫发作,并可能改善预后。白话摘要:在抗生素和皮质激素问世之前,由常见的肺炎双球菌引起的脑膜(大脑的覆盖层)感染曾是一种致命疾病。多亏了这些药物,越来越多的人得以幸存,但由于并发症频发,他们可能会留下多种后遗症。癫痫发作是一种常见的并发症。我们的研究表明,可以通过使用抗癫痫药物来预防癫痫发作,这样可以降低严重程度,缩短住院时间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Seizure prophylaxis in pneumococcal meningitis, cohort study

Objective

Our aim was to assess seizure development as a complication of pneumococcal meningitis and its possible prevention with antiseizure medication prophylaxis.

Methods

Antiseizure medication (ASM) prophylaxis has been practiced for a long time at our center. We assessed all cases of community-acquired pneumococcal meningitis admitted from January 2010 to April 2021 recorded in our prospective database and conducted further retrospective studies.

Results

Of the 86 cases recorded, 21 (24.4%) developed acute symptomatic seizures, more than half of which (11/21; 52.4%) before admission. Seizure development increased the need for orotracheal intubation and intensive care unit admission, while also lengthening hospital stays and suggesting more risk of death and disability at discharge [adjusted odds ratio (aOR), 3.13; 95% confidence interval (CI): 1–9.8]. Of the 74 patients eligible for ASM prophylaxis, 64 received it and 10 did not. ASM prophylaxis seemed effective in preventing seizure development, as only six seizure events were recorded in 64 patients with ASM prophylaxis (9.4%) compared with four in the 10 patients without prophylaxis (40%). Its preventive capacity was especially notable when administered within 4 h of admission. Differences in mortality did not reach statistical significance. Adverse effects were rare.

Significance

Seizure development is a common complication in pneumococcal meningitis and is associated with increased risks of Intensive Care Unit admission, orotracheal intubation, and longer hospital stays. ASM prophylaxis may be effective in blocking seizure development in patients with preventable seizures and may be associated with better prognosis. Further studies are now warranted.

Plain Language Summary

Infection of the meninges (the covering of the brain) due to the common bacteria S pneumoniae, used to be a fatal disease before the introduction of antibiotics and corticoids. Thanks to these drugs, more people survive this disease but, due to the frequent complications, they may have several sequelae. Seizures are a common complication. Our study suggests that they might be prevented by using antiseizure drugs which may reduce both severity and hospital stay.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Epilepsia Open
Epilepsia Open Medicine-Neurology (clinical)
CiteScore
4.40
自引率
6.70%
发文量
104
审稿时长
8 weeks
期刊最新文献
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW). Three cases of atypical Rasmussen's encephalitis with delayed-onset seizures. GATAD2B-related developmental and epileptic encephalopathy (DEE): Extending the epilepsy phenotype and a literature appraisal. Intrinsic brain network stability during kainic acid-induced epileptogenesis. Diagnostic yield of utilizing 24-72-hour video electroencephalographic monitoring in the diagnosis of seizures presenting as paroxysmal events in resource-limited settings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1